Pharmaceutical
-
GRAM Opens Cleanroom and Formulation Facility
7-10-2020Grand River Aseptic Manufacturing (GRAM) opened a $60 million facility for injectable fill-and-finish operations in June of 2020.
-
Trammell Crow Constructs Fulton Labs Development
6-26-2020Trammell Crow Company will break ground in July of 2020 on Fulton Labs in Chicago.
-
Sanofi Pasteur Plans Vaccine Research and Production Facilities
6-24-2020Sanofi Pasteur is planning to create the Evolutive Vaccine Facility (EVF) in Neuville sur Saône, France.
-
South Australian Health and Medical Research Institute Begins Construction on SAHMRI 2
6-15-2020The South Australian Health and Medical Research Institute will begin construction in July of 2020 on the SAHMRI 2 building in Adelaide.
-
Life Sciences Construction Remains Solid
6-10-2020Amid sobering reports of job losses in commercial real estate, coupled with months-long construction shutdowns in major markets like Boston and New York, the life sciences sector is poised to experience a less dramatic disruption, and possibly emerge from the pandemic even stronger than it was before. “COVID is a healthcare crisis, so it needs a healthcare solution, and that life sciences and biophparma solution has to be constructed,” says Kevin Chronley, vice president of A/Z Corp. and immediate past president of the Boston Area Chapter of International Society for Pharmaceutical Engineering (ISPE). Chronley predicts that construction will run the gamut from medical device manufacturing and biopharma laboratories to education and training facilities.
-
Ryvu Therapeutics Completes R&D Center for Innovative Drugs
6-9-2020Ryvu Therapeutics completed construction in June of 2020 on the R&D Center for Innovative Drugs in Krakow, Poland.
-
Genomic Partnership Wales Designs Research Facility
6-5-2020Genomic Partnership Wales is planning to construct a research facility in Cardiff in the United Kingdom to accelerate the development of pharmaceutical therapies.
-
Catalent Increases Bloomington Manufacturing Capacity for SARS-CoV-2 Vaccine Candidate
6-4-2020Catalent is rapidly scaling up its manufacturing capacity in Bloomington to enable production of a SARS-CoV-2 vaccine candidate that is currently being by developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
-
POINT Biopharma Plans Indianapolis Manufacturing Facility
6-2-2020POINT Biopharma, a clinical-stage pharmaceutical company based in Canada, is establishing its first U.S. manufacturing center in Indianapolis.
-
Exyte Partners with Univercells to Create Modular Vaccine Development Facilities
5-26-2020Exyte is partnering with Univercells Technologies to create modular biomanufacturing facilities to meet the increased global demand for vaccines during the SARS-CoV-2 pandemic.
